VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHOC 2022 | The impact of reduced intensity conditioning for allogeneic SCT in AML

Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses the impact of reduced intensity conditioning for allogeneic stem cell transplantation (alloSCT) in acute myeloid leukemia (AML). Prof. Nagler first explains the high toxicity associated with previous forms of myeloablative conditioning, and then goes on to comment on how reduced intensity conditioning has improved the efficacy and safety of transplantation over the years. This interview took place at the XIII Eurasian Hematology-Oncology Congress (EHOC) held in Istanbul, Turkey.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter